Sign in
4/A

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001601830-24-000102

Chief Executive Officer acquired 100,000 shares (conversion)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gibson Christopher · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-05 Conversion : show line 1 in the form 10b5-1 +100,000 908,738 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-05 Conversion : show line 2 in the form 10b5-1 Class B Common Stock −100,000 6,326,700 D
Loading xslF345X05/wk-form4a_1720824741.xml…